148 related articles for article (PubMed ID: 36944795)
1. Transcriptome sequencing identifies prognostic genes involved in gastric adenocarcinoma.
Li M; Bai M; Wu Y; Yang S; Zheng L; Sun L; Yu C; Huang Y
Mol Cell Biochem; 2023 Dec; 478(12):2891-2906. PubMed ID: 36944795
[TBL] [Abstract][Full Text] [Related]
2. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
Alatan H; Chen Y; Zhou J; Wang L
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
[TBL] [Abstract][Full Text] [Related]
5. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
6. Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways.
Zhao L; Lei H; Shen L; Tang J; Wang Z; Bai W; Zhang F; Wang S; Li W
Mol Med Rep; 2017 Aug; 16(2):1232-1240. PubMed ID: 28586067
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
Zhang W; Liu S; Zhan H; Yan Z; Zhang G
Mol Med Rep; 2018 Oct; 18(4):3673-3682. PubMed ID: 30106143
[TBL] [Abstract][Full Text] [Related]
8. Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma.
Li Y; Luo Y; Tian Q; Lai Y; Xu L; Yun H; Liang Y; Liao D; Gu R; Liu L; Yuan M; Li Y; Li Y; Lu M; Yong X; Zhang H
J Oncol; 2022; 2022():9080460. PubMed ID: 35726219
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
10. SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating EMT.
Yang JD; Ma L; Zhu Z
J Chemother; 2019; 31(7-8):408-418. PubMed ID: 31724495
[TBL] [Abstract][Full Text] [Related]
11. P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.
Song H; Liu L; Song Z; Ren Y; Li C; Huo J
Technol Cancer Res Treat; 2018 Jan; 17():1533033818796485. PubMed ID: 30198421
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
13. Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
Wu PL; He YF; Yao HH; Hu B
Med Sci Monit; 2018 Jan; 24():348-355. PubMed ID: 29343680
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
15. MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
Zhou HY; Wu CQ; Bi EX
World J Gastroenterol; 2019 Dec; 25(47):6823-6834. PubMed ID: 31885423
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract.
Xiaoyan F; Mingzhe LI; Long C; Chao L; Wenli LU; Zhiqiang P; Dongwei J; Peike P; Zhaoqin F; Xiaomei L
J Tradit Chin Med; 2022 Dec; 42(6):922-931. PubMed ID: 36378050
[TBL] [Abstract][Full Text] [Related]
17. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics.
Ding C; Zhang Q; Jiang X; Wei D; Xu S; Li Q; Wu M; Wang H
Comput Math Methods Med; 2022; 2022():4321466. PubMed ID: 35756405
[TBL] [Abstract][Full Text] [Related]
18. Global transcriptome‑wide analysis of the function of GDDR in acute gastric lesions.
Zhang Z; Zhu J; Dong Y; Xu H; Jiang T; Li W; Xu D; Shi L; Yu J; Zhang J; Du J
Mol Med Rep; 2017 Dec; 16(6):8673-8684. PubMed ID: 28990076
[TBL] [Abstract][Full Text] [Related]
19. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
20. A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.
Yu C; You M; Zhang P; Zhang S; Yin Y; Zhang X
Cancer Med; 2021 Jul; 10(13):4629-4643. PubMed ID: 34121340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
